Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Uterine Neoplasms 1Stomach Neoplasms 1Solid Neoplasm 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

Oxaliplatin 7Irinotecan 4Mitomycin 3Leucovorin 3Fluorouracil 3Cisplatin 3Capecitabine 3Trastuzumab 2Interleukin-12 Subunit p35 2Hyperthermic Intraperitoneal Chemotherapy 2Doxorubicin 2tipifarnib 1sodium thiosulfate 1irinotecan sucrosofate 1entinostat 1dehydroftorafur 1Thalidomide 1Platinum 1Pharmacogenomic Testing 1Mitozytrex 1Interleukin-12 1Floxuridine 1Erlotinib Hydrochloride 1Docetaxel 1Cytoreduction Surgical Procedures 1Cetuximab 1Biopsy 17-hydroxystaurosporine 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Appendiceal Neoplasms × Mitozytrex × Clear all
NCT04329494 2025-12-10

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

City of Hope Medical Center

Phase 1 Recruiting
49 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡